STOCK TITAN

Ellomay Capital (NYSE: ELLO) awards 1,000 stock options to non-employee director

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ellomay Capital Ltd. director Odelya Ohayon received an annual grant of 1,000 stock options on August 1, 2026 under the 1998 Share Option Plan for Non-Employee Directors. The options cover 1,000 ordinary shares at an exercise price of 19.6000 per share, become exercisable on August 1, 2027, expire on August 1, 2036, and are subject to her continuing to serve on the board on the exercisability date.

Positive

  • None.

Negative

  • None.
Insider Ohayon Odelya
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) F1, F2 1,000 $0.00 $0.00
Holdings After Transaction: Stock Option (right to buy) — 1,000 shares (Direct)
Footnotes (2)
  1. F1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.
  2. F2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.
Options Granted 1000.0000 options Annual grant to non-employee director on August 1, 2026
Exercise Price 19.6000 per share Conversion or exercise price of the stock options
Underlying Ordinary Shares 1000.0000 shares Shares subject to the reported stock option grant
Total Derivative Holdings After Grant 1000.0000 options Total derivative securities following the reported transaction
Exercise Date 2027-08-01 Date on which the options become exercisable, subject to board service
Expiration Date 2036-08-01 Final expiration date of the stock options
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
1998 Share Option Plan for Non-Employee Directors financial
"grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors"
exercise price financial
"conversion_or_exercise_price: 19.6000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
underlying security financial
"underlying_security_title: Ordinary Shares"
expiration date financial
"expiration_date: 2036-08-01"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Odelya Ohayon report for Ellomay Capital (ELLO)?

Odelya Ohayon reported a grant of 1,000 stock options on August 1, 2026. The options relate to 1,000 ordinary shares, have an exercise price of 19.6000 per share, and expire on August 1, 2036, as part of director compensation.

Is the Ellomay Capital (ELLO) Form 4 a stock purchase or sale?

The Form 4 reports a grant of stock options, not a market purchase or sale. The transaction is coded "A" for grant or award, reflecting compensation to a non-employee director under Ellomay Capital’s 1998 Share Option Plan.

What are the key terms of the 1,000 Ellomay Capital (ELLO) options granted?

The director received 1,000 options for Ellomay Capital ordinary shares with an exercise price of 19.6000 per share. The options become exercisable on August 1, 2027 and expire on August 1, 2036, providing a long-dated equity incentive.

Are the Ellomay Capital (ELLO) options subject to any service conditions?

Yes. Exercisability of the options on August 1, 2027 is subject to Odelya Ohayon serving as a member of Ellomay Capital’s board on that date. This ties the equity award to continued board service as a non-employee director.

How many Ellomay Capital (ELLO) derivative securities does the director hold after this grant?

Following this transaction, the reporting person holds 1,000 derivative securities related to Ellomay Capital ordinary shares. These represent the full amount of the newly granted stock options reported in this Form 4 filing.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ohayon Odelya

(Last)(First)(Middle)
18 ROTHSCHILD BLVD.

(Street)
TEL AVIV6688121

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ellomay Capital Ltd. [ ELLO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
[ELLO]
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$19.608/01/2026(1)A1,00008/01/2027(2)08/01/2036Ordinary Shares1,000$01,000D
Explanation of Responses:
1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.
2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.
/s/ Odelya Ohayon08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)